About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
MGUS: Disease Definitions, Diagnostic Approaches and Risk Stratification
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Morie Gertz
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Morie Gertz
388 views
March 18, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
13:43
Houston Methodist Hospital
Lung Involvement in Amyloidosis
Feat.
H. Huang
28:20
PleXus Communications
Why We Should Not Treat SMM
Feat.
B. Derman
04:15
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…
Feat.
M. Gertz
11:55
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy &…
Feat.
O. Landgren
10:25
Morie Gertz
"You Have AL-Amyloidosis": Counseling Newly Diagnosed Pati…
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
19:39
Yale Cancer Center
AL Amyloidosis Treatment Updates
Feat.
T. Parker
32:06
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…
Feat.
M. Gertz
52:39
Yale Cancer Center
Myeloma in 2023: So Many Drugs, Yet So Few Cures
Feat.
A. Chari
41:54
University of Colorado Division of Hematology
Overview of Pathophysiology, Diagnosis and Management of Multiple My…
Feat.
K. Sidor
22:15
5th SOHO Italy Annual Conference
SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …
Feat.
K. Anderson
21:03
Yale Cancer Center
Renal AL Amyloid
Feat.
R. Luciano
10:23
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …
Feat.
T. Einarsson Long
04:55
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering …
Feat.
S. Thorsteinsdottir
27:05
American Society of Nuclear Cardiology
Interpreting a PYP Study for TTR Cardiac Amyloid
Feat.
P. Soman,
M. Harinstein,
S. Divakaran
27:26
Houston Methodist Hospital
FDA Perspective on New Therapies for Amyloidosis
Feat.
R. Adigun
19:10
Houston Methodist Hospital
Amyloidosis: Pathophysiology
Feat.
S. Ganguly
30:34
Houston Methodist Hospital
Current Treatment Options for AL Amyloidosis
Feat.
K. Baker
12:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed …
Feat.
E. Kastritis
